Hologic Given New $29.00 Price Target at ISI Group (HOLX)
Research analysts at ISI Group boosted their target price on shares of Hologic (NASDAQ:HOLX) from $27.00 to $29.00 in a report released on Wednesday. ISI Group’s price objective would indicate a potential upside of 13.68% from the stock’s previous close.
A number of other analysts have also recently weighed in on HOLX. Analysts at BTIG Research downgraded shares of Hologic from a “buy” rating to a “neutral” rating in a research note on Monday. Separately, analysts at Standpoint Research downgraded shares of Hologic from a “buy” rating to a “hold” rating in a research note on Wednesday, July 2nd. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Hologic in a research note on Wednesday, June 25th. They now have a $26.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have assigned a buy rating to the company. Hologic has a consensus rating of “Hold” and an average target price of $23.94.
Shares of Hologic (NASDAQ:HOLX) traded up 0.71% during mid-day trading on Wednesday, hitting $25.51. 1,498,387 shares of the company’s stock traded hands. Hologic has a 52-week low of $18.68 and a 52-week high of $26.18. The stock’s 50-day moving average is $24.89 and its 200-day moving average is $22.62. The company’s market cap is $7.049 billion.
Hologic (NASDAQ:HOLX) last posted its quarterly earnings results on Wednesday, April 30th. The company reported $0.37 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.33 by $0.04. The company had revenue of $625.00 million for the quarter, compared to the consensus estimate of $609.35 million. Analysts expect that Hologic will post $1.40 EPS for the current fiscal year.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.